Real world clinical feasibility of direct-from-specimen antimicrobial susceptibility testing of clinical specimens with unknown microbial load or susceptibility.

If there is no significant change of signal levels across each specimen dilution, the sample is considered to be R and moves onto the next step; if there is a significant drop in signal levels and/or a decreasing trend in either specimen dilution, the sample is reported S.

also in 47,180 other papers